.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Covington
Mallinckrodt
Baxter
Argus Health
Johnson and Johnson
Chubb
Healthtrust
Queensland Health
Harvard Business School

Generated: July 22, 2017

DrugPatentWatch Database Preview

RIFADIN Drug Profile

« Back to Dashboard

What is the patent landscape for Rifadin, and what generic Rifadin alternatives are available?

Rifadin is a drug marketed by Sanofi Aventis Us and is included in three NDAs.

The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the rifampin profile page.

Summary for Tradename: RIFADIN

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list22
Clinical Trials: see list15
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIFADIN at DailyMed

Pharmacology for Tradename: RIFADIN

Ingredient-typeRifamycins
Drug ClassRifamycin Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
RIFADIN
rifampin
CAPSULE;ORAL062303-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
RIFADIN
rifampin
CAPSULE;ORAL050420-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Sanofi Aventis Us
RIFADIN
rifampin
INJECTABLE;INJECTION050627-001May 25, 1989APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Queensland Health
Colorcon
Cipla
UBS
Merck
Argus Health
Boehringer Ingelheim
Johnson and Johnson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot